← Back to Search

Behavioral Intervention

CAPAS-yOUTH Parenting Program for Hispanic Immigrants

N/A
Recruiting
Led By Jose R Parra-Cardona, Ph.D.
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Youth: 12-14 years old
Parent: Spanish speaking
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline adolescent drug use to 9 months
Awards & highlights

Study Summary

This trial is investigating a culturally adapted version of an evidence-based parenting intervention delivered to parents of Hispanic immigrants in mid-Texas. The intervention is designed to help parents with common parenting challenges, and the trial will measure implementation barriers and outcomes to inform a future study on scaling the intervention.

Who is the study for?
This trial is for Hispanic or Latino parents, aged 18 or older, who are first-generation immigrants in mid-Texas. They must speak Spanish and face financial challenges. Their family should include a US-born child aged 12-14 with reported behavior issues. Participants need to consent to join a parenting program.Check my eligibility
What is being tested?
The study tests CAPAS-Youth, an adaptation of the GenerationPMTO intervention designed for Hispanic immigrant parents. It aims to refine this faith-based program within churches and understand barriers to its implementation among underserved communities.See study design
What are the potential side effects?
Since this is a behavioral intervention focusing on parenting skills rather than medical treatment, there are no direct physical side effects expected from participating in the CAPAS-Youth program.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 12 and 14 years old.
Select...
I am a Spanish-speaking parent.
Select...
I am a parent and I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline adolescent drug use to 9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline adolescent drug use to 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adolescent Drug Use: change in youths' drug use from baseline to 9 months
Adolescent Perceived Risk of Drug Use: change in youths' perceived risk of drug use from baseline to 9 months
Family Problem Solving: change in problem solving skills from baseline to 9 months
+5 more
Secondary outcome measures
Bicultural Involvement: change in parents and youth acculturation from baseline to 9 months
Immigration-related Stress: change in parents' immigration related stress from baseline to 9 months

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CAPAS Youth Parenting InterventionExperimental Treatment1 Intervention
11-week CAPAS-Youth culturally adapted intervention
Group II: Wait-list controlActive Control1 Intervention
Participants allocated to this condition receive the intervention until all assessments are completed for both arms in each cohort

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor
358 Previous Clinical Trials
81,326 Total Patients Enrolled
2 Trials studying Parenting
318 Patients Enrolled for Parenting
Jose R Parra-Cardona, Ph.D.Principal InvestigatorThe University of Texas at Austin
1 Previous Clinical Trials
168 Total Patients Enrolled
1 Trials studying Parenting
168 Patients Enrolled for Parenting

Media Library

CAPAS-yOUTH (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05291481 — N/A
Parenting Research Study Groups: CAPAS Youth Parenting Intervention, Wait-list control
Parenting Clinical Trial 2023: CAPAS-yOUTH Highlights & Side Effects. Trial Name: NCT05291481 — N/A
CAPAS-yOUTH (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05291481 — N/A
~64 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top